Weight loss reduces asthma severity in obese adults, finds study

A Canadian study published in the June issue of the journal CHEST found weight loss reduced asthma severity as measured by airway hyperresponsiveness (AHR) in obese adults. The incidence of asthma is 1.47 times higher in obese people than nonobese people, and a three-unit increase in body mass index is associated with a 35% increase in the risk of asthma. The study supports the active treatment of comorbid obesity in individuals with asthma.

The study, the first of its kind to rely on appropriate physiologic tests as diagnostic criteria for asthma, found normalization or improvements in AHR, asthma control, and quality of life.

"While previous studies have examined the relationship between asthma severity and obesity, this study is unique because of its strict adherence to an accurate diagnostic criteria and study outcome (AHR), resulting in purer results to support weight loss as a strategy to normalize or reverse asthma in this group of people hit very hard by the condition," said Smita Pakhale, MD, Department of Medicine, The Ottawa Hospital and University of Ottawa. "We were pleased to see significant improvement in asthma symptoms, as well as quality of life for these individuals. This study further supports the need to manage comorbidities to improve patient lives."

The entire study, Effects of Weight Loss on Airway Responsiveness in Obese Adults With Asthma: Does Weight Loss Lead to Reversibility of Asthma?, can be viewed in the June issue of CHEST.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Diabetes drugs cut asthma attacks by up to 70%, reshaping treatment options